Trial Profile
An Open, Randomized, Two-way Cross-over Phase I Study to Compare the Bioavailability, Safety and Tolerability of Single s.c. Doses of 300 IU XM17 With 300 IU Gonal-f in 36 Healthy, Down-regulated Young Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary) ; Goserelin
- Indications Female infertility
- Focus Pharmacokinetics
- Sponsors Merckle
- 02 Nov 2015 New trial record